ADAR1 Capital Management »

Proqr Thrapeutics N V shs euro shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Proqr Thrapeutics N V shs euro (PRQR) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Proqr Thrapeutics N V shs euro

Tip: Access up to 7 years of quarterly data

All positions including Proqr Thrapeutics N V shs euro held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Proqr Thrapeutics N V shs euro by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $21k 10k 2.13
2025-06-30 $20k 10k 2.04
2025-03-31 $27k 20k 1.33
2024-12-31 $54k 20k 2.65

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Keros Therapeutics (KROS)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Roivant Sciences SHS (ROIV)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Immunovant (IMVT)
89bio (ETNB)
Zai Lab Adr (ZLAB)
Cytokinetics Com New (CYTK)
Septerna (SEPN)
Uniqure Nv SHS (QURE)
Prothena Corp SHS (PRTA)
Bridgebio Pharma (BBIO)
Arbutus Biopharma (ABUS)

View all positions for ADAR1 Capital Management

Top funds holding Proqr Thrapeutics N V shs euro

Adage Capital Partners GP
Privium Fund Management B.V.
Affinity Asset Advisors
Morgan Stanley
Standard Life Aberdeen
Sio Capital Management
Kynam Capital Management
DAFNA Capital Management
Siren
Arrowpoint Asset Management
Platinum Investment Mangement
M28 Capital Management
Ikarian Capital
Point72 Asset Management
Citadel Advisors

View all funds holding Proqr Thrapeutics N V shs euro